Perspective Therapeutics Inc (AMEX: CATX) kicked off on Tuesday, up 11.81% from the previous trading day, before settling in for the closing price of $2.54. Over the past 52 weeks, CATX has traded in a range of $1.60-$5.39.
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -9.86%. While this was happening, its average annual earnings per share was recorded 0.32%. With a float of $61.65 million, this company’s outstanding shares have now reached $74.34 million.
Perspective Therapeutics Inc (CATX) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Medical Devices Industry. The insider ownership of Perspective Therapeutics Inc is 17.07%, while institutional ownership is 63.28%. The most recent insider transaction that took place on Nov 13 ’25, was worth 22,295. In this transaction Chief Accounting Officer of this company bought 11,000 shares at a rate of $2.03, taking the stock ownership to the 59,800 shares. Before that another transaction happened on Nov 12 ’25, when Company’s Director bought 9,498 for $2.10, making the entire transaction worth $19,946. This insider now owns 9,864 shares in total.
Perspective Therapeutics Inc (CATX) Latest Financial update
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -0.24 earnings per share (EPS), higher than consensus estimate (set at -0.25) by 0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.35 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 0.32% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -0.62% during the next five years compared to -9.86% drop over the previous five years of trading.
Perspective Therapeutics Inc (AMEX: CATX) Trading Performance Indicators
Take a look at Perspective Therapeutics Inc’s (CATX) current performance indicators. Last quarter, stock had a quick ratio of 8.66. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 197.31.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.46, a number that is poised to hit -0.36 in the next quarter and is forecasted to reach -1.33 in one year’s time.
Technical Analysis of Perspective Therapeutics Inc (CATX)
The latest stats from [Perspective Therapeutics Inc, CATX] show that its last 5-days average volume of 2.1 million was superior to 1.11 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 74.64%.
During the past 100 days, Perspective Therapeutics Inc’s (CATX) raw stochastic average was set at 25.78%, which indicates a significant decrease from 92.94% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.20 in the past 14 days, which was lower than the 0.26 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.82, while its 200-day Moving Average is $3.01. Now, the first resistance to watch is $3.01. This is followed by the second major resistance level at $3.18. The third major resistance level sits at $3.46. If the price goes on to break the first support level at $2.56, it is likely to go to the next support level at $2.28. The third support level lies at $2.11 if the price breaches the second support level.
Perspective Therapeutics Inc (AMEX: CATX) Key Stats
The company with the Market Capitalisation of 211.12 million has total of 74,338K Shares Outstanding. Its annual sales at the moment are 1,450 K in contrast with the sum of -79,280 K annual income. Company’s last quarter sales were recorded 210 K and last quarter income was -25,970 K.
